Trials / Conditions / Thrombosis, Venous

Thrombosis, Venous

18 registered clinical trials studyying Thrombosis, Venous — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	The ReCAna for Lower ExtremIty Venous OBstructions and In-StEnt Restenosis Registry NCT07529756	Intervene, Inc.	—
Recruiting	The Impact of MTM Model on the Efficacy and Safety of Anticoagulant Therapy in Postoperative Colorectal Cancer NCT06998745	Sixth Affiliated Hospital, Sun Yat-sen University	N/A
Recruiting	Acute and Subacute Iliofemoral and/or Caval Deep Vein Thrombosis: Evaluation of Mechanical Thrombectomy System NCT06288906	IRCCS San Raffaele	—
Recruiting	Venous Thrombosis After Removal of Central Venous Catheter NCT06349291	Meir Medical Center	—
Recruiting	The Use of Thrombin Generation Assay in Detection of Central Line Related Thrombosis (CRT) in Critically Ill P NCT06094387	Queen Mary Hospital, Hong Kong	—
Not Yet Recruiting	Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Pati NCT06149533	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Phase 3
Unknown	Bioimpedance Measurement of Abdominal Free Flaps During Arterial and Venous Weaning in Breast Reconstruction NCT05710705	Centre Hospitalier Universitaire, Amiens	N/A
Active Not Recruiting	Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective S NCT05396157	Mount Sinai Hospital, Canada	—
Completed	Catheter Associated Asymptomatic Thrombosis in Intensive Care Unit NCT04503135	Policlinico Hospital	—
Completed	Recurrence and Bleeding in Colorectal Cancer Patients With Cancer-associated Venous Thrombembolism NCT06440044	Sixth Affiliated Hospital, Sun Yat-sen University	—
Completed	ARIXTRA® Adherence in SVT Patients. NCT01691495	GlaxoSmithKline	—
Completed	Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery NCT01444612	GlaxoSmithKline	—
Completed	Hemorrhage Risk Prescribed Arixtra NCT01064362	GlaxoSmithKline	—
Completed	A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patien NCT00843492	GlaxoSmithKline	Phase 3
Completed	The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients NCT00911157	GlaxoSmithKline	Phase 3
Completed	Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superfi NCT00443053	GlaxoSmithKline	Phase 3
Completed	Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer NCT00312013	GlaxoSmithKline	Phase 3
Completed	Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium) NCT00320398	GlaxoSmithKline	Phase 3